Company page
Bioinvent International Ab
Bioinvent International Ab is a public company listed on the UK market under the ticker 0H22. The company has a market capitalization of approximately £158 million. Bioinvent focuses on the development of innovative therapies for cancer treatment.
- Ticker
- BINV:OMXSTO
- Asset type
- Stock
- Market cap
- $158.1M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- OMXSTO
- Currency
- SEK